Funding
Researcher : Beatriz Pelacho Samper
7 funding - 778,945€
2025
2023
-
Targeted NANOmedicine to reverse FIBrosis in ischemic cardiomyopathies
euro 124,630.00
-
Targeted NANOmedicine to reverse FIBrosis in ischemic cardiomyopathies
euro 124,630.00
-
Cribado CRISPR funcional para identificar nuevas dianas epigenéticas mediadoras de la transformación fibrótica en el remodelado cardiaco adverso
euro 135,520.00